Founded in 2011, Signo is a high-tech enterprise specializing in the development, production and sales of in vitro diagnostic reagents.
The company has established a strict quality management system and passed ISO9001: 2015 and ISO13485: 2016 international quality system certifications.
It has advanced international fully automatic production equipment, and the workshop is designed in strict accordance with standards and has reached 10,000-level purification standards. Signo has strong biotechnology power, and currently has more than 60 independent intellectual property rights, including 2 invention patents, and undertakes many provincial and municipal science and technology innovation projects.The products are mainly related to microorganisms / clinical reagents, medical equipment / robot...
